TITLE

Coagulation parameters in inflammatory bowel disease

AUTHOR(S)
Dolapcioglu, Can; Soylu, Aliye; Kendir, Tulin; Ince, Ali Tuzun; Dolapcioglu, Hatice; Purisa, Sevim; Bolukbas, Cengiz; Sokmen, Haci Mehmet; Dalay, Remzi; Ovunc, Oya
PUB. DATE
June 2014
SOURCE
International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 5, p1442
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Thromboembolic events represent a major cause of morbidity and mortality in patients with inflammatory bowel disease and they may occur both at the gastrointestinal tract and at extraintestinal sites. This study aimed to examine the alterations in coagulation parameters involved at different steps of hemostasis in patients with Crohn's disease and ulcerative colitis, in comparison with healthy individuals. Fifty-one patients with inflammatory bowel disease and 26 healthy controls were included in this study. Plasma levels of PT, APTT, AT III, plasminogen, fibrinogen, D-dimer, factor V, factor VIII, protein C, protein S, and APCR were measured and factor V Leiden mutation was examined in both patients and controls. Two patients with ulcerative colitis had a history of previous thromboembolic event. Inflammatory bowel disease was associated with significantly higher levels of fibrinogen, PT, factor V, factor VIII, plasminogen and thrombocyte. Protein S, fibrinogen, plasminogen and thrombocyte levels were associated with disease activity, depending on the type of the disease (Crohn's disease or ulcerative colitis). The coagulation abnormalities detected in this study seems to be a secondary phenomena resulting from the disease process, which is more likely to be associated with a multitude of factors rather than a single abnormality.
ACCESSION #
96422503

 

Related Articles

  • Overview On Inflammatory Bowel Disease. EL Sayed, Engy Yousry // Nature & Science;Aug2013, Vol. 11 Issue 8, p1 

    Ulcerative colitis (UC) and Crohn's disease (CD) (collectively termed inflammatory bowel disease (IBD)) are complex disorders reflected by wide variation in clinical practice. Ulcerative colitis is characterized by diffuse mucosal inflammation limited to the colon. Crohn's disease is...

  • Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens. Danese, Silvio; Papa, Alfredo; Saibeni, Simone; Repici, Alessandro; Malesci, Alberto; Vecchi, Maurizio // American Journal of Gastroenterology;Jan2007, Vol. 102 Issue 1, p174 

    Inflammation and coagulation play crucial roles in the pathogenesis of multiple chronic inflammatory disorders. Growing evidence highlights a tight mutual network in which inflammation, coagulation, and fibrinolysis play closely related roles. Crohn's disease (CD) and ulcerative colitis (UC),...

  • Crohn's Disease.  // Crohn's Disease (National Digestive Diseases Info Clearinghouse);2006, Vol. 06 Issue 3410, p1 

    The article discusses the nature of the Crohn's disease. It explains that the disease is an ongoing disorder which causes inflammation of the digestive tract or gastrointestinal (GI) tract. It outlines the symptoms and causes of the disease, as well as its similarity to irritable bowel syndrome...

  • The Gut Microbiota in Inflammatory Bowel Disease. Macfarlane, G. T.; Blackett, K. L.; Nakayama, T.; Steed, H.; Macfarlane, S. // Current Pharmaceutical Design;5/1/2009, Vol. 15 Issue 13, p1528 

    Crohn's disease and ulcerative colitis are the two principal forms of inflammatory bowel disease (IBD). The root causes of these chronic and acute immunological disorders are unclear, but intestinal microorganisms are known to play a key role in the initiation and maintenance of disease....

  • Effects of Inflammatory Bowel Diseases on Bone Metabolism. Sylvester, Francisco A. // IBMS BoneKEy;Nov2009, p420 

    Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions that involve the gastrointestinal tract and affect approximately 1.2 million Americans, of whom 25% are diagnosed as children. The incidence of IBD is increasing worldwide. The term IBD encompasses two distinct entities,...

  • World Gastroenterology Organisation Global Guideline: Inflammatory bowel disease: a global perspective - June 2009. Bernstein, Charles N.; Fried, Michael; Krabshuis, J. H.; Cohen, Henry; Eliakim, R.; Fedail, Suleiman; Gearry, Richard; Goh, K. L.; Hamid, Saheed; Khan, Aamir Ghafor; LeMair, A. W.; Malfertheiner, P.; Qin Ouyang; Rey, J.-F.; Sood, Ajit; Steinwurz, Flavio; Thomsen, Ole Ø.; Thomson, Alan; Watermeyer, Gillian // South African Gastroenterology Review;Aug2010, Vol. 8 Issue 2, p13 

    The article presents the global guideline for inflammatory bowel disease (IBD) from the World gastroenterology Organisation. It notes that IBD contains a group of idiopathic chronic inflammatory intestinal illnesses which has two main disease types such as Crohn's disease (CD) and ulcerative...

  • Optimize Dietary Strategies for Inflammatory Bowel Disease.  // Women's Health Advisor;Oct2012, Vol. 16 Issue 10, p5 

    The article discusses the causes and consequences of inflammatory bowel disease (IBD) and offers dietary strategies to prevent IBD. It defines IBD is a chronic interruptive disease of the gastrointestinal (GI) tract with symptoms of diarrhea, abdominal cramping or pain, or blood in the stool. It...

  • Lymphatic pump function in the inflamed gut.  // Inflammatory Bowel Disease Monitor;2011, Vol. 11 Issue 3, p125 

    The article presents a review on the pathological features of the lymphatic system that are seen in the inflammatory bowel disease (IBD) patients. It notes that ulcerative colitis (UC) and Crohn's diseases are chronic inflammatory disorders of the gastrointestinal (GI) tract. It discusses the...

  • The lL-8 and IL-13 Gene Polymorphisms in Inflammatory Bowel Disease and Colorectal Cancer. Walczak, Anna; Przybylowska, Karolina; Dziki, Lukasz; Sygut, Andrzej; Chojnacki, Cezary; Chojnacki, Jan; Dziki, Adam; Majsterek, Ireneusz // DNA & Cell Biology;Aug2012, Vol. 31 Issue 8, p1431 

    Inflammatory bowel diseases (IBD) and colorectal cancer (CRC) are disorders that originate from immune disturbances. In our study, we evaluated the association between the −251 T/A interleukin ( IL) -8 and the −1112 C/T IL-13 polymorphisms, the risk of IBD, and CRC development....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics